Search research articles
Contact Us
Filters
Showing results (1-10 of 747) with videos related to
Page
of 75
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 8, 2014
Serum alanine aminotransferase as a biomarker of treatment response in nonalcoholic steatohepatitis
Rohit Loomba
Hepatology (Baltimore, Md.)
|
November 12, 2020
MRI-Proton Density Fat Fraction Treatment Response Criteria in Nonalcoholic Steatohepatitis
Rohit Loomba
Journal of Hepatology
|
December 6, 2017
Role of imaging-based biomarkers in NAFLD: Recent advances in clinical application and future research directions
Rohit Loomba
Hepatology (Baltimore, Md.)
|
July 22, 2014
Rationale for conducting a randomized trial to examine the efficacy of metformin in improving survival in cirrhosis: pleiotropic effects hypothesis
Rohit Loomba
Cureus
|
January 1, 2016
Thrombocytosis in the Setting of Isomerism and a Functionally Univentricular Heart
Rohit Loomba
Gastroenterology & Hepatology
|
May 26, 2021
Role of Noninvasive Biomarkers in the Diagnosis of Nonalcoholic Steatohepatitis With Stage 2 or 3 Fibrosis
Rohit Loomba
Gastroenterology
|
June 28, 2015
The Hierarchical Model of NAFLD: Prognostic Significance of Histologic Features in NASH
Rohit Loomba, Naga Chalasani
Seminars in Liver Disease
|
February 23, 2018
Can Elastography Differentiate Isolated Fatty Liver from Nonalcoholic Steatohepatitis?
Veeral Ajmera, Rohit Loomba
Current Treatment Options in Gastroenterology
|
March 15, 2021
An update on the role of the microbiome in non-alcoholic fatty liver disease pathogenesis, diagnosis, and treatment
Marialena Mouzaki, Rohit Loomba
Nature Reviews. Gastroenterology & Hepatology
|
August 31, 2018
Gut microbiome, microbial metabolites and the development of NAFLD
Cyrielle Caussy, Rohit Loomba
Page
of 75
Search research articles
Search
Showing results (1-10 of 747) with videos related to
Sort By:
Page
of 75
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 8, 2014
Serum alanine aminotransferase as a biomarker of treatment response in nonalcoholic steatohepatitis
Rohit Loomba
Hepatology (Baltimore, Md.)
|
November 12, 2020
MRI-Proton Density Fat Fraction Treatment Response Criteria in Nonalcoholic Steatohepatitis
Rohit Loomba
Journal of Hepatology
|
December 6, 2017
Role of imaging-based biomarkers in NAFLD: Recent advances in clinical application and future research directions
Rohit Loomba
Hepatology (Baltimore, Md.)
|
July 22, 2014
Rationale for conducting a randomized trial to examine the efficacy of metformin in improving survival in cirrhosis: pleiotropic effects hypothesis
Rohit Loomba
Cureus
|
January 1, 2016
Thrombocytosis in the Setting of Isomerism and a Functionally Univentricular Heart
Rohit Loomba
Gastroenterology & Hepatology
|
May 26, 2021
Role of Noninvasive Biomarkers in the Diagnosis of Nonalcoholic Steatohepatitis With Stage 2 or 3 Fibrosis
Rohit Loomba
Gastroenterology
|
June 28, 2015
The Hierarchical Model of NAFLD: Prognostic Significance of Histologic Features in NASH
Rohit Loomba, Naga Chalasani
Seminars in Liver Disease
|
February 23, 2018
Can Elastography Differentiate Isolated Fatty Liver from Nonalcoholic Steatohepatitis?
Veeral Ajmera, Rohit Loomba
Current Treatment Options in Gastroenterology
|
March 15, 2021
An update on the role of the microbiome in non-alcoholic fatty liver disease pathogenesis, diagnosis, and treatment
Marialena Mouzaki, Rohit Loomba
Nature Reviews. Gastroenterology & Hepatology
|
August 31, 2018
Gut microbiome, microbial metabolites and the development of NAFLD
Cyrielle Caussy, Rohit Loomba
Page
of 75